Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-31

FDA Approved: ARIPIPRAZOLE — Supplemental Application (VistaPharm, LLC)

View source ↗

Summary

FDA approved a supplemental application for aripiprazole filed by VistaPharm, LLC, marking approval of a supplemental submission for this generic drug. This con…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)

Snippet

SUPPL AP for ARIPIPRAZOLE (ARIPIPRAZOLE)